{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Cartuche L"],"funding":["Universidad Técnica Particular de Loja, Ecuador","Ministerio de Economía y Competitividad","Programa Agustín de Bethancourt, Cabildo de Tenerife, Spain"],"pagination":["11651"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6690954"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["9(1)"],"pubmed_abstract":["Recently, the search for novel therapeutic agents against Acanthamoeba species has been focused on the evaluation of natural resources. Among them, marine microorganisms have risen as a source of bioactive compounds with the advantage of the ability to obtain unlimited and constant amounts of the compounds in contrast to other natural sources such as plants. Furthermore, marine actinomycetes have recently been reported as highly rich in bioactive agents including salinosporamides, xiamycines, indolocarbazoles, naphtyridines, phenols, dilactones such as antimycines and macrolides among others. In this study, staurosporine (STS) was isolated from a strain of Streptomyces sanyensis and tested against Acanthamoeba to characterize the therapeutic potential of STS against this protozoan parasite"],"journal":["Scientific reports"],"pubmed_title":["Staurosporine from Streptomyces sanyensis activates Programmed Cell Death in Acanthamoeba via the mitochondrial pathway and presents low in vitro cytotoxicity levels in a macrophage cell line."],"pmcid":["PMC6690954"],"funding_grant_id":["PI18/01380"],"pubmed_authors":["Pinero JE","Javier Fernandez J","Lorenzo-Morales J","Reyes-Batlle M","Diaz-Marrero AR","Cruz D","Lopez-Arencibia A","Sifaoui I","Cartuche L"],"additional_accession":[]},"is_claimable":false,"name":"Staurosporine from Streptomyces sanyensis activates Programmed Cell Death in Acanthamoeba via the mitochondrial pathway and presents low in vitro cytotoxicity levels in a macrophage cell line.","description":"Recently, the search for novel therapeutic agents against Acanthamoeba species has been focused on the evaluation of natural resources. Among them, marine microorganisms have risen as a source of bioactive compounds with the advantage of the ability to obtain unlimited and constant amounts of the compounds in contrast to other natural sources such as plants. Furthermore, marine actinomycetes have recently been reported as highly rich in bioactive agents including salinosporamides, xiamycines, indolocarbazoles, naphtyridines, phenols, dilactones such as antimycines and macrolides among others. In this study, staurosporine (STS) was isolated from a strain of Streptomyces sanyensis and tested against Acanthamoeba to characterize the therapeutic potential of STS against this protozoan parasite","dates":{"release":"2019-01-01T00:00:00Z","publication":"2019 Aug","modification":"2025-05-31T23:17:43.725Z","creation":"2025-05-31T23:17:43.725Z"},"accession":"S-EPMC6690954","cross_references":{"pubmed":["31406269"],"doi":["10.1038/s41598-019-48261-7"]}}